本文へ

This website uses cookies for usage measurement and traffic analysis purposes.
By clicking the "Agree" button or continuing to browse this site, you consent to the use of cookies.
For more details, please refer to the Privacy Policy別ウィンドウで開く (opens in a new window).

Agree

ATLAS Asia Clinical Trials Network for Cancers Project
menu
  1. Home
  2. Member Search
  3. Takuji Okusaka (奥坂 拓志)

Takuji Okusaka (奥坂 拓志) , MD, PhD

Title (Affiliation)
Chief - Department of Hepatobiliary and Pancreatic Oncology
Facility Name

National Cancer Center Hospital, Japan

Department Department of Hepatobiliary and Pancreatic Oncology
Specialized Treatment Chemotherapy
奥坂 拓志の写真

Dr. Takuji Okusaka’s Story

Dr. Okusaka specializes in chemotherapy for liver cancer, biliary tract cancer, pancreatic cancer, and neuroendocrine tumors.
He has been committed to developing better treatments to prolong patients’ prognosis and improve their quality of life.

Research Interest

Development of novel therapies for liver cancer, biliary tract cancer, pancreatic cancer, and neuroendocrine tumors

Professional Experience

Chair, Committee for Revision of Clinical Practice Guideline for Pancreatic Cancer
Chair, Committee for Revision of Clinical Practice Guideline for Biliary tract Cancer
Member of the Committee for the Development of LCSGJ ICC Guidelines
Evaluation Committee Member of Clinical Practice Guidelines for Gastroenteropancreatic Neuroendocrine Neoplasms

Specialized field

Chemotherapy

Qualifications, certified physicians, medical specialists

Board Certified Member of the Japanese Society of Internal Medicine
Board Certified Member of the Japanese Society of Gastroenterology
Board Certified Member of the Japan Biliary Association
Board Certified Expert in Pancreatology

PAGE TOP